About James Kearns, MD
James Kearns, MD, a urologist at Endeavor Health, provides care for men with prostate cancer and prostate-related conditions. He is dedicated to shared decision-making, helping patients understand their diagnosis and navigate treatment options that balance quality and longevity of life. With a background in longitudinal care, Dr. Kearns brings specialized expertise to a deeply personal area of men’s health.
My endeavor
My endeavor is to take care of men with prostate cancer, helping them understand every aspect of their condition and create a plan that provides the best quality and quantity of life.
Care philosophy
I believe in shared decision-making. I help patients understand their disease and treatment options, talk through the decisions, and then provide the best care I can in a supportive environment.
Overview
- Gender Male
Conditions treated (4)
- Prostate cancer
- Prostate disease
- Benign prostatic hyperplasia (BPH)
- Elevated PSA
Procedures performed (13)
- Robot prostatectomy
- Transrectal ultrasonography (TRUS)
- Transurethral resection of prostate (TURP)
- Simple prostatectomy
- Aquablation
- MRI fusion guided prostate biopsy
- Transperineal ultrasonography (TPUS) and guided biopsy
- Transrectal ultrasonography (TRUS) and guided biopsy
- Robotic prostatectomy
- Robotic simple prostatectomy
- Spaceoar
- Transurethral resection of the prostate (TURP)
- Trans perineal and trans rectal biopsies
-
Endeavor Health Medical Group
1000 Central St., Suite 720 Evanston, IL 60201-1779 -
Endeavor Health Medical Group
767 Park Ave. West, Suite B100 Highland Park, IL 60035-2469 -
Endeavor Health Medical Group
2180 Pfingsten Rd., Suite 3000 Glenview, IL 60026-1340
-
2010Columbia University College of Physicians and Surgeons
-
2012SurgeryUniversity of Illinois at Chicago
-
2016UrologyUniversity of Chicago Hospitals
-
2018Urologic OncologyUniversity of Washington Hospital
-
2020UrologyAmerican Board of Urology
-
Clinical Assistant Professor, The University of Chicago Pritzker School of Medicine
Pharmaceutical, device, and biotechnology companies frequently collaborate with research scientists and physicians to help advance scientific knowledge and improve patient care. These relationships can support scientific breakthroughs and help establish the effectiveness and safety of promising new therapies.
To ensure objectivity in clinical research and patient care, Endeavor Health maintains integrity policies requiring researchers and clinicians — whether in full-time, part-time and unpaid or voluntary roles — to disclose compensated and uncompensated relationships with external industry organizations.
Patients are encouraged to discuss these relationships with their physician as well as to inquire as to how these relationships are overseen by Endeavor Health. Learn more about our Conflict of Interest and Commitment Policy.
Additionally, patients can visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website, a national disclosure program that promotes a more transparent and accountable healthcare system. It houses a publicly accessible database of payments that reporting entities — including pharmaceutical, device, and biotechnology companies — make to covered recipients such as physicians and hospitals.
CMS is required by law to publish this data annually on or before June 30 for the previous reporting year. The data is published annually, so it may not reflect the most recent reporting period. If you have questions about the information, talk with your physician.

